Showing results (131-140 of 161) with videos related to
Sort By:
Pageof 17
The Science of the Total Environment|November 16, 2010
Correlation analysis of noise and ultrafine particle counts in a street canyonA Can, M Rademaker, T Van Renterghem, et al.Cancer Chemotherapy and Pharmacology|February 20, 2007
Phase I and pharmacokinetic trial of AP5346, a DACH-platinum-polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patientsMario Campone, Jeany M Rademaker-Lakhai, Jaafar Bennouna, et al.British Heart Journal|August 1, 1985
Plasma free captopril concentrations during short and long term treatment with oral captopril for heart failureT R Shaw, F M Duncan, B C Williams, et al.Journal of Cardiovascular Electrophysiology|May 3, 2001
Arrhythmogenesis in heart failureM J Janse, J T Vermeulen, T Opthof, et al.American Journal of Obstetrics and Gynecology|August 28, 2012
Gas embolism during hysteroscopic surgery using bipolar or monopolar diathermia: a randomized controlled trialBirgitte A Dyrbye, Lucilla E Overdijk, Paul J van Kesteren, et al.European Journal of Preventive Cardiology|June 28, 2013
Comparison of different cardiac risk scores for coronary artery disease in symptomatic women: do female-specific risk factors matter?Anouk A E M Rademaker, Ibrahim Danad, Jan G J Groothuis, et al.The British Journal of Dermatology|August 1, 1987
Nifedipine in the treatment of Raynaud's phenomenon in patients with systemic sclerosisR H Meyrick Thomas, M Rademaker, S M Grimes, et al.The Journal of Antimicrobial Chemotherapy|November 1, 1990
A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitisC M Rademaker, A P Sips, H M Beumer, et al.Antimicrobial Agents and Chemotherapy|October 1, 1990
Pharmacokinetics of cefepime in patients with respiratory tract infectionsJ M Kovarik, J C ter Maaten, C M Rademaker, et al.Anti-Cancer Drugs|September 16, 2005
Phase I clinical and pharmacologic study of a 2-weekly administration of cisplatin and gemcitabine in patients with advanced non-small cell lung cancerJeany M Rademaker-Lakhai, Mirjam Crul, Dick Pluim, et al.Pageof 17